Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction

BACKGROUND: Breast cancer is the most common malignancy in women. Clinical models such as Oncotype DX recurrence score (RS) and Clinical Treatment Score post–5 years (CTS5) model for survival prediction are crucial for clinical practice. However, it remains unclear whether CTS5 or RS would be a more...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changjun, Xu, Ying, Lin, Yan, Zhou, Yidong, Mao, Feng, Zhang, Xiaohui, Shen, Songjie, Zhang, Yanna, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942860/
https://www.ncbi.nlm.nih.gov/pubmed/35334240
http://dx.doi.org/10.1016/j.breast.2022.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942860/
https://www.ncbi.nlm.nih.gov/pubmed/35334240
http://dx.doi.org/10.1016/j.breast.2022.03.007

Ejemplares similares